CERE - Cerevel Therapeutics Holdings - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

CERE is currently covered by 6 analysts with an average potential upside of $9.45 (35.1%) from yesterday's end of day stock price of $41.25. Cerevel Therapeutics Holdings activity chart has currently 7 price targets and 24 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 54% with an average time for these price targets to be met of 96.7 days.

Highest price target for CERE is $41, Lowest price target is $21, average price target is $31.

Most recent stock forecast was given by CHARLES DUNCAN from CANTOR FITZGERALD on 07-Dec-2023. First documented stock forecast 10-Dec-2020.

Currently, out of the existing stock ratings of CERE - 12 which are a Hold (60%), 8 which are a Buy (40%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

45

$3.75 (9.09%)

46

3 days ago

1/3 (33.33%)

$3.89 (9.46%)

434

Hold

25

$-16.25 (-39.39%)

29

4 months 3 days ago

8/8 (100%)

$4.45 (21.65%)

67

Buy

42

$20.17 (92.40%)

40

4 months 7 days ago

2/5 (40%)

$13.08 (57.19%)

28

Buy

41

$19.17 (87.81%)

45

4 months 7 days ago

0/5 (0%)

$19.34 (73.84%)

Hold

30

$-11.25 (-27.27%)

28

6 months 17 days ago

3/3 (100%)

$-3.27 (-9.83%)

22

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CERE (Cerevel Therapeutics Holdings) average time for price targets to be met?

On average it took 96.7 days on average for the stock forecasts to be realized with a an average price target met ratio 54

Which analyst has the current highest performing score on CERE (Cerevel Therapeutics Holdings) with a proven track record?

MATTHEW HARRISON

Which analyst has the most public recommendations on CERE (Cerevel Therapeutics Holdings)?

Matthew Harrison works at MORGAN STANLEY and has 7 price targets and 7 ratings on CERE

Which analyst is the currently most bullish on CERE (Cerevel Therapeutics Holdings)?

Cory Kasimov with highest potential upside - $21.2

Which analyst is the currently most reserved on CERE (Cerevel Therapeutics Holdings)?

Graig Suvannavejh with lowest potential downside - -$16.25

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart